Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/18010
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSurintip Piamsomboonen_US
dc.contributor.authorAndrzej P. Kudelkaen_US
dc.contributor.authorWichai Termrungruanglerten_US
dc.contributor.authorKoen Van Besienen_US
dc.contributor.authorCreyhton L. Edwardsen_US
dc.contributor.authorSamuel Lifshitzen_US
dc.contributor.authorDonald F. Schomeren_US
dc.contributor.authorRichard Champlinen_US
dc.contributor.authorRosario P. Manteen_US
dc.contributor.authorJohn J. Kavanaghen_US
dc.contributor.authorClaire F. Verschraegenen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUniversity of Texas MD Anderson Cancer Centeren_US
dc.contributor.otherChulalongkorn Universityen_US
dc.contributor.otherPresbyterian Hospital of Dallasen_US
dc.date.accessioned2018-07-04T07:46:08Z-
dc.date.available2018-07-04T07:46:08Z-
dc.date.issued1997-12-17en_US
dc.identifier.citationEuropean Journal of Gynaecological Oncology. Vol.18, No.6 (1997), 453-456en_US
dc.identifier.issn03922936en_US
dc.identifier.other2-s2.0-9844255061en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=9844255061&origin=inwarden_US
dc.identifier.urihttp://repository.li.mahidol.ac.th/dspace/handle/123456789/18010-
dc.description.abstractGestational trophoblastic disease (GTD) metastatic to the brain has a very poor prognosis with a survival rate of less than 25%, especially for patients in whom brain metastases develop while on or after chemotherapy. Cure can be achieved by chemotherapy alone. The regimen of etoposide, methotrexate, actinomycin-D, vincristine, and cyclophosphamide has shown encouraging results and is considered to be standard first-line treatment for high risk patients. For patients in whom this regimen fails, a salvage chemotherapy regimen is used. The combination of ifosfamide, carboplatin, and etoposide (ICE) has synergistic activity in preclinical studies. This regimen has shown activity in metastatic breast cancer and non-small-cell lung cancer as well as platinum-resistant germ-cell tumors and metastatic GTD. This is the first report of a patient with a highly refractory GTD in whom brain metastasis developed while on chemotherapy, and whose brain metastasis went into remission with a low dose ICE regimen. Accordingly, ICE may be considered for patients with chemotherapy refractory GTD metastatic to the brain.en_US
dc.rightsMahidol Universityen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=9844255061&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleRemission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE): First report and review of literatureen_US
dc.typeArticleen_US
dc.rights.holderSCOPUSen_US
Appears in Collections:Scopus 1991-2000

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.